Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi (IST:MEDTR)
Turkey · Delayed Price · Currency is TRY 24.56
-0.12 (-0.49%)
At close: Sep 4, 2026
IST:MEDTR Revenue
Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi had revenue of 668.47M TRY in the quarter ending June 30, 2026, a decrease of -18.31%. This brings the company's revenue in the last twelve months to 2.57B, down -18.98% year-over-year. In the year 2025, Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi had annual revenue of 2.87B with 4.83% growth.
Revenue (ttm)
2.57B
Revenue Growth
-18.98%
P/S Ratio
1.14
Revenue / Employee
3.35M
Employees
768
Market Cap
2.92B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.87B | 132.29M | 4.83% |
| Dec 31, 2024 | 2.74B | 644.58M | 30.74% |
| Dec 31, 2023 | 2.10B | 501.03M | 31.40% |
| Dec 31, 2022 | 1.60B | 1.22B | 324.48% |
| Dec 31, 2021 | 375.93M | 16.61M | 4.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.